Tenet Healthcare CorpTHC
Price$253.97Intrinsic value$410.8462% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $410.84median of 6 methods · middle span $102-$1,082based on filings through 30 Jun 2026
Market Price $253.97Price as of 1 Oct 2026
Margin of Safety +61.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 16.1% (near-term consensus, capped) · years 2–5: 9.4%/yr (balance of the path).10.7% per year
Years 6–10: glide to demonstrated growth own history 40.4%, capped at 20%
Per-year rates
Yr 69.7%Yr 710.0%Yr 810.2%Yr 910.5%Yr 1010.7%
9.4% → 10.7%
Years 11–20: glide to long-run rate
Per-year rates
Yr 1110.0%Yr 129.2%Yr 138.4%Yr 147.6%Yr 156.9%Yr 166.1%Yr 175.3%Yr 184.5%Yr 193.8%Yr 203.0%
10.7% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (5/7y) (limited history)40.4%
Discount rate (cost of equity) 10.2%
Volatility vs market (adjusted beta)1.17

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetTenet Healthcare CorpTHCHealth Care
Valuation
P/E9.8×
P/S1.0×
P/B4.7×
EV / Revenue1.5×
EV / EBITDA5.3×
Profitability
Gross margin—
Operating margin20.8%
Net margin14.6%
FCF margin13.9%
Returns
ROE68.1%
ROA10.3%
ROIC20.4%
Growth
Revenue growth (YoY)5.5%
5-yr fwd EPS growth10.7%
Financial strength
Debt / Equity2.81×
Current ratio1.41×
Altman Z-Score2.1
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.